Trial Profile
Ziprasidone versus risperidone in the treatment of chronic schizophrenia: A six months, double blind randomized, parallel group study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Pfizer
- 26 Nov 2013 Treatment table added.
- 14 Apr 2008 New trial record.